Renewed multi-year partnership to support Ferring Pharmaceuticals' operations in response to rapid business growth NEW YORK , Nov. 21, 2024 /PRNewswire/ -- Genpact (NYSE: G), a global professional services and solutions firm delivering outcomes that shape the future, today announced the extension of its partnership with Ferring Pharmaceuticals, a research-driven biopharmaceutical company that h...
Fourth consecutive year of recognition highlights Genpact's expertise in sourcing and procurement, strong partner ecosystem, and advanced technology capabilities driving transformation for clients worldwide NEW YORK , Nov. 20, 2024 /PRNewswire/ -- Genpact (NYSE: G), a global professional services and solutions firm delivering outcomes that shape the future, today announced that it has been name...
Recognition is a testament to Genpact's commitment to positive employee experience and engagement, and its culture of learning and innovation NEW YORK , Nov. 18, 2024 /PRNewswire/ -- Genpact (NYSE: G), a global professional services and solutions firm delivering outcomes that shape the future, today announced its inclusion on the Forbes list of World's Best Employers 2024 for the fourth consec...
Genpact's deep insurance and advanced technology expertise drive transformation and agility NEW YORK , Nov. 13, 2024 /PRNewswire/ -- Genpact (NYSE: G), a global professional services and solutions firm delivering outcomes that shape the future, today announced that it has been named a Leader in the inaugural edition of Avasant's 2024 Insurance Business Process Transformation RadarView™ report....
Strategic business development leader Jinsook Han joins Genpact to spearhead strategy and M&A NEW YORK , Nov. 12, 2024 /PRNewswire/ -- Genpact (NYSE: G), a global professional services and solutions firm delivering outcomes that shape the future, today announced that Jinsook Han has joined the Company as Chief Strategy and Corporate Development Officer, effective immediately. She will be respon...
Total Revenue of $1.21 billion, Up 7% (7% constant currency) 1 Diluted EPS of $0.74, Up 16%; Adjusted Diluted EPS 2 of $0.85, Up 12% NEW YORK , Nov. 7, 2024 /PRNewswire/ -- Genpact Limited (NYSE: G), a global professional services and solutions firm delivering outcomes that shape the future, today announced financial results for the third quarter ended September 30, 2024. "We delivered strong ...
Strengthens Genpact's advanced technology offerings as an AWS Premier Tier Services Partner with full suite of AI, data and analytics, and machine learning AWS Competencies NEW YORK , Nov. 1, 2024 /PRNewswire/ -- Genpact (NYSE: G), a global professional services and solutions firm delivering outcomes that shape the future, announced it has achieved the Amazon Web Services (AWS) Generative AI Co...
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.